2005
DOI: 10.1128/mcb.25.19.8607-8618.2005
|View full text |Cite
|
Sign up to set email alerts
|

New Functions of the Major Histocompatibility Complex Class II-Specific Transcription Factor RFXANK Revealed by a High-Resolution Mutagenesis Study

Abstract: The transcription factors RFX and CIITA are major players in regulation of the expression of all classical and nonclassical major histocompatibility complex class II (MHC-II) genes. RFX nucleates the formation of a multiprotein complex, called the MHC-II enhanceosome, on MHC-II promoters. Assembly of this enhanceosome is an obligatory step for recruitment of the coactivator CIITA and thus for activation of MHC-II gene transcription. We have analyzed the function of the ankyrin repeat-containing protein RFXANK,… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
21
0

Year Published

2008
2008
2024
2024

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 21 publications
(23 citation statements)
references
References 52 publications
2
21
0
Order By: Relevance
“…Notably, RFX5 was recovered as the top partner for RFXANK (Table S2) and one of the top ones for ANKRA2 (Table S1). RFXANK forms a trimeric transcription factor complex with RFX5 and RFXAP (Reith and Mach, 2001;Ting and Trowsdale, 2002) and ANKRA2 may play a similar role (Krawczyk et al, 2005;Long and Boss, 2005). In addition, ANKRA2 coprecipitated HDAC5 (Table S1), which is consistent with the published reports that ANKRA2 interacts with this deacetylase (McKinsey et al, 2006;Wang et al, 2005;Xu et al, 2012).…”
Section: Resultssupporting
confidence: 89%
See 1 more Smart Citation
“…Notably, RFX5 was recovered as the top partner for RFXANK (Table S2) and one of the top ones for ANKRA2 (Table S1). RFXANK forms a trimeric transcription factor complex with RFX5 and RFXAP (Reith and Mach, 2001;Ting and Trowsdale, 2002) and ANKRA2 may play a similar role (Krawczyk et al, 2005;Long and Boss, 2005). In addition, ANKRA2 coprecipitated HDAC5 (Table S1), which is consistent with the published reports that ANKRA2 interacts with this deacetylase (McKinsey et al, 2006;Wang et al, 2005;Xu et al, 2012).…”
Section: Resultssupporting
confidence: 89%
“…This motif is conserved in the Drosophila homolog of RFX5 and RFX7 ( Figures S3A-S3C). The MPxLPxL motif of RFX5 mediates association with RFXANK (Xu et al, 2012), although this may not be the sole surface for RFXANK association (Krawczyk et al, 2005). Interaction of RFX7 with RFXANK or ANKRA2 has not been reported, but the high similarity to RFX5 suggests that RFX7 may utilize its PxLPxL motif to bind ANKRA2 and RFXANK ( Figure S3).…”
Section: Resultsmentioning
confidence: 96%
“…Mutations in the RFX-B gene cause immunodeficiency by producing the bare lymphocyte syndrome (Masternak et al, 1998). Krawczyk et al (2005) indicated that increasing the expression of ANKRA2 activates MHC-II expression, demonstrating that both genes (ANKRA2 and RFX-B) have a similar capacity to activate transcription of the MHC-II genes. Further studies need to be conducted to ascertain whether ANKRA2 is associated with the incidence of multiple pathogenic diseases in cattle.…”
Section: Discussionmentioning
confidence: 99%
“…The Ankyrin-repeat protein 2 (ANKRA2) lies between markers BMS1282 and TGLA304 (W. Snelling, US Meat Animal Research Center, Clay Center, NE, personal communication). This gene may play a major role in the regulation of the major histocompatibility complex class II (MHC-II) genes (Krawczyk et al, 2005;McKinsey et al, 2006). The MHC-II is responsible for the immunological response in livestock.…”
Section: Discussionmentioning
confidence: 99%
“…The Raji, HHK, RJ2.2.5, BLS1, SJO, 6.1.6, DA, and ABI cell lines, as well as CIITA-complemented RJ2.2.5 cells, RFXANK-complemented BLS1 cells, RFX5-complemented SJO cells, and RFXAP-complemented 6.1.6 and DA cells, have all been described (37)(38)(39)(40). The BLS3 cell line was established from a skin biopsy of an MHCII-deficient BLS patient.…”
Section: Cells and Culturementioning
confidence: 99%